Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Succinic Semialdehyde Dehydrogenase Deficiency: Physiological Markers of Taurine Therapy

NCT01608178 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT01608178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01608178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Succinic Semialdehyde Dehydrogenase Deficiency: Physiological Markers of Taurine Therapy
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Observational
Overall status
Completed
Start date
April 27, 2012
Completion date
December 16, 2013
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

succinic semialdehyde dehydrogenase